汇垠天粤怎么样

汇垠天粤是一家在股权投资领域具有重要影响力的公司。

广州汇垠天粤股权投资基金管理有限公司成立于 2014 年 4 月，是广州基金旗下聚焦产业股权投资、助推广州国有企业混改的市场化运作核心平台。它设多家控股及参股平台公司，共同管理资产规模接近 800 亿元。

汇垠天粤以优化广州市产业投资，促进本土高端、高质、高新现代产业新体系构建为己任，主要围绕新一代信息技术、汽车、高端装备、生物医药、新材料及新能源、生产性服务业等重点产业投资。截至 2019 年上半年，汇垠天粤直接管理产业投资规模达 350.70 亿元，当中直接出资 147.47 亿元，引导社会投资 203.23 亿元。其中，PIPE 项目 80.93 亿元，PE 项目 24.96 亿元，固收项目 25.48 亿元，政府基金项目 16.10 亿元。具体投资项目包括 AI 四小龙之一云从科技、高科技医疗项目欧欧医疗、国内免疫组化试剂龙头迈新生物、新能源高端装备制造明阳智能等。从产业发展战略角度出发，推动万孚生物、广电计量、宇信科技等企业上市，参股广汽集团、鼎汉技术等 A 股上市公司。

汇垠天粤一直积极参与广州市国企混改，自 2015 年就率先开始与广汽资本发起国企混改基金，探索提升国企混改模式，积极推动广州国企改革发展。汇垠天粤充分发挥“国企+金融”的优势，紧密围绕“产业”、“股权”、“混改”、“市场化运作”的发展定位，经过多年的经营运营，已逐步发展成为国内极具影响力和市场活力的专业股权投资机构之一。

在招聘方面，汇垠天粤对于风控部实习生有着明确的要求，包括国家重点大学在读本科或硕士研究生（研一优先），法律专业，985、211 院校优先等。同时，也提供了相应的实习机会和补贴。

然而，关于汇垠天粤的评价也并非全是正面。有人曾对其股权情况提出疑问，但并未给出明确的结论。

总的来说，汇垠天粤在股权投资领域有着显著的成绩和一定的影响力，但也面临着各种挑战和市场的考验。对于投资者和相关从业者来说，需要综合多方面的因素来评估其价值和潜力。

How about Huiyin Tianyue

Huiyin Tianyue is a company with significant influence in the field of equity investment.

Guangzhou Huiyin Tianyue Equity Investment Fund Management Co., Ltd. was established in April 2014 and is a core platform for market-oriented operations under Guangzhou Fund, focusing on industrial equity investment and promoting the mixed-ownership reform of state-owned enterprises in Guangzhou . It has several holding and equity participation platform companies, with a combined asset management scale of nearly 80 billion yuan.

Huiyin Tianyue takes it as its responsibility to optimize industrial investment in Guangzhou and promote the construction of a new local modern industrial system that is high-end, high-quality, and high-tech. It mainly invests in key industries such as the new generation of information technology, automobiles, high-end equipment, biomedicine, new materials and new energy, and productive service industries. As of the first half of 2019, Huiyin Tianyue's directly managed industrial investment scale reached 35.07 billion yuan, of which 14.747 billion yuan was directly invested and 20.323 billion yuan was from guiding social investment. Among them, the PIPE project was 8.093 billion yuan, the PE project was 2.496 billion yuan, the fixed-income project was 2.548 billion yuan, and the government fund project was 1.610 billion yuan. Specific investment projects include Yun Cong Technology, one of the "AI Four Little Dragons", the high-tech medical project Ouou Medical, the domestic leader in immunohistochemical reagents Maxin Biotechnology, and the new energy high-end equipment manufacturer Mingyang Smart Energy. From the perspective of industrial development strategy, it has promoted the listing of enterprises such as Wanfu Biological, Guangdian Measurement, and Yuxin Technology, and participated in A-share listed companies such as GAC Group and Dinghan Technology.

Huiyin Tianyue has been actively involved in the mixed-ownership reform of state-owned enterprises in Guangzhou. Since 2015, it has taken the lead in initiating the mixed-ownership reform fund with GAC Capital, exploring and improving the mixed-ownership reform model of state-owned enterprises, and actively promoting the reform and development of state-owned enterprises in Guangzhou. Huiyin Tianyue gives full play to the advantages of "state-owned enterprises + finance", closely focuses on the development positioning of "industry", "equity", "mixed-ownership reform", and "market-oriented operation". After years of operation, it has gradually developed into one of the professional equity investment institutions with great influence and market vitality in China.

In terms of recruitment, Huiyin Tianyue has clear requirements for interns in the risk control department, including undergraduate or postgraduate students (priority for the first year of postgraduate study) from national key universities, majoring in law, with priority given to 985 and 211 institutions. At the same time, it also provides corresponding internship opportunities and subsidies.

However, the evaluations of Huiyin Tianyue are not all positive. Some people have raised questions about its equity situation, but no clear conclusion has been given.

In general, Huiyin Tianyue has achieved remarkable results and has certain influence in the field of equity investment, but it also faces various challenges and tests of the market. For investors and related practitioners, it is necessary to comprehensively consider various factors to evaluate its value and potential.